RecallDepth
Class II Terminated

Elelyso (taliglucerase alfa) for injection, 200 units/vials,, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017. NDC 0069-0106-01

Company
Pfizer Inc.
Recall Initiated
February 27, 2020
Posted
March 11, 2020
Recall Number
D-0995-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
24,714 vials
Firm Location
New York, NY, United States

Reason for Recall

Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.

Distribution

Nationwide within the United States and Albania, Israel, Serbia, Macedonia, Afghanistan, Botswana/South Africa/Zimbabwe, India, Israel, Rwanda, Uruguay, Mongolia

Lot / Code Info

Lot #: X14209, Exp. Date 02/2020; AH4601, Exp. Date 03/2020; AH4603, X46389, X78365, AT2927, Exp. Date 04/2020; AH4602, Exp. Date 05/2020; AL8590, Exp. Date 10/2020

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls